Pacific Gastroenterology Associates

Vancouver, British Columbia V6Z 2K5

3 studies enrolling now · 8 studies all time

What they study most

Cirrhosis, Colitis, Ulcerative, Colon Adenoma, Colon Lesion, Colon Polyp, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), NASH - Nonalcoholic Steatohepatitis, Prevention of Esophageal Varices, Primary Biliary Cholangitis, SBS Associated With Intestinal Failure (SBS-IF), Short Bowel Syndrome (SBS)

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) — Recruiting now
• St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C) — Recruiting now
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC — Completed
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed